drugset / Trial / NCT01254383

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.

NCT01254383 ↗

Phase 1 Completed 36 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties as the conventional tablet of sildenafil.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2011-03

Outcome

Mixed primary results

paper Sildenafil ODT without water was bioequivalent to the marketed sildenafil film-coated oral tablet PMID 24447534 ↗

paper the 90% CI for sildenafil Cmax was not (79.76-92.78). PMID 24447534 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral

Indications